W. Rosen, R. Mohs, and K. Davis, A new rating scale for Alzheimer's disease, Am J Psychiatry, vol.141, pp.1356-1364, 1984.

R. Hartman and M. Gharabawi, Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial, Bmj, vol.318, pp.633-638, 1999.

J. Birks, Cholinesterase inhibitors for Alzheimer's disease, Cochrane Database Syst Rev, vol.11, issue.suppl 2, p.5593, 2006.
DOI : 10.1002/14651858.CD005593

L. Schneider, The post-modern world of Alzheimer's disease trials: how much is an ADAS-cog point worth in central London?, International Journal of Geriatric Psychiatry, vol.336, issue.1, pp.9-13, 2006.
DOI : 10.1002/gps.1492

A. Takeda, E. Loveman, A. Clegg, J. Kirby, J. Picot et al., A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, p.14

D. Hogan, Donepezil for severe Alzheimer's disease, The Lancet, vol.367, issue.9516, pp.1031-1032, 2006.
DOI : 10.1016/S0140-6736(06)68395-5

C. Jeandel, M. Joel, P. Jouanny, F. Lebert, P. Michot et al., Consensus statement on dementia of Alzheimer type in the severe stage, J Nutr Health Aging, vol.9, pp.330-338, 2005.

H. Feldman and M. Woodward, The staging and assessment of moderate to severe

B. Vellas, The REAL.FR research program on Alzheimer's disease and its management: methods and preliminary results, J Nutr Health Aging, vol.7, pp.91-96, 2003.
URL : https://hal.archives-ouvertes.fr/inserm-00924505

G. Mc-khann, D. Drachman, M. Folstein, R. Katzman, D. Price et al., Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, vol.34, issue.7, pp.939-944, 1984.
DOI : 10.1212/WNL.34.7.939

M. Folstein, S. Folstein, and P. Mchugh, ???Mini-mental state???, Journal of Psychiatric Research, vol.12, issue.3, pp.189-192, 1975.
DOI : 10.1016/0022-3956(75)90026-6

D. Commenges, L. Letenneur, P. Joly, A. Alioum, and J. Dartigues, Modelling age-specific risk: application to dementia, Statistics in Medicine, vol.17, issue.17, pp.1973-1988, 1998.
DOI : 10.1002/(SICI)1097-0258(19980915)17:17<1973::AID-SIM892>3.0.CO;2-5

J. Hui, R. Wilson, D. Bennett, J. Bienias, D. Gilley et al., Rate of cognitive decline and mortality in Alzheimer's disease, Neurology, vol.61, issue.10, pp.1356-1361, 2003.
DOI : 10.1212/01.WNL.0000094327.68399.59

H. Nguyen, S. Black, L. Ray, D. Espino, and K. Markides, Cognitive Impairment and Mortality in Older Mexican Americans, Journal of the American Geriatrics Society, vol.11, issue.2, pp.178-183, 2003.
DOI : 10.1046/j.1532-5415.2003.51055.x